Explore our Services | Halloran Consulting Group

An Integrated Development Plan (IDP) intricately merges an organization's nonclinical, chemistry, manufacturing and controls (CMC), regulatory, quality, and clinical strategies. It functions as a cohesive roadmap, aligning executive management and program teams on advancing new drugs, devices, or targets through the life sciences development process. Key features include:

Roadmap for Progress: Providing a clear path from discovery to commercialization
Alignment Tool: Ensuring coherence among stakeholders, outlining milestones, successes, and challenges
Fundraising Support: Assisting in M&A discussions and grant proposals
Optimized Timelines: Guiding asset development efficiently
Risk Management: Offering program-wide risk assessments and mitigation strategies

Applicable across all development stages, from startups to global life sciences companies, the IDP revolves around the Target Product Profile (TPP), outlining product characteristics and development objectives.

The IDP's scope can encompass the entire development program or focus on specific milestones like an Investigational New Drug (IND) filing. Continuously evolving, it adapts to emerging data, changing assumptions, and evolving risks.

Central to the IDP's efficacy is its ability to align stakeholders, enhancing development process efficiency and effectiveness.